Pharmacy Website
    Clinic Website

    Intelligence » Hepatitis C » Last Week

    Subscribe to get latest posts via email or subscribe to a RSS feed.

    Lymphoma incidence 15 times higher in HIV/HCV coinfection

    Sunday, April 15, 2018 -- The incidence of lymphoma — Hodgkin and non-Hodgkin — was up to 15 times higher among patents with HIV monoinfection and HIV/hepatitis C virus coinfection compared with the general population, according to findings presented at the International Liver Congress in Paris.Alvaro Mena de Cea, MD, PhD, of the Institute of Biomedical Research and La Coruña University Hospital Complex in Spain, and colleagues used a database at their tertiary care hospital to compare the incidence of HL and NHL among patients with HIV and HIV/HCV coinfection with that of the general population

    DAA therapy effective in patients with HCV and advanced cirrhosis

    Monday, April 16, 2018 -- PARIS — Direct-acting antiviral therapy effectively treated hepatitis C virus in patients with high MELD scores, producing a high rate of sustained viroloic response, according to a presentation at the International Liver Congress 2018.“Real-life SVR rates with DAAs in patients with advanced liver disease ranged from 85% to 100% and were comparable to clinical trial experience. Ribavirin did not influence SVR in this cohort,” Elizabeth C. Verna, MD, of Columbia University, said in her presentation. “Over the year following treatment, stabilization or marginal

    Alcohol, cannabis use have no impact on HCV cure rates

    Saturday, April 14, 2018 -- PARIS — Although sustained virologic response maintained a high level no matter the alcohol or cannabis consumption in a German registry, those who reported drinking alcohol in excess were more likely to be lost to follow-up, according to a presentation at the International Liver Congress 2018.“Alcohol or cannabis consumption did not diminish cure rates,” Stefan Christensen, MD, from Center for Interdisciplinary Medicine, Munster, Germany, said during his presentation. “However, loss to follow-up is more likely in patients with current or former drug use compared to

    Patients with chronic HCV at higher risk for ICD-10-classified diseases

    Monday, April 16, 2018 -- Patients with chronic hepatitis C virus infection are at a higher risk of being diagnosed with around 70% of the diseases captured by the ICD-10, according to a presentation at the International Liver Congress in Paris.Jonas Söderholm , PhD, affiliate scientist at the Karolinska Institute and medical advisor for AbbVie, and colleagues used the ICD-10 classification B18.2 to identify patients with chronic hepatitis C (CHC) in the nationwide Swedish Patient Register (n = 42,522), including those receiving inpatient care, day surgery and nonprimary outpatient care, from 2001 through 2013.“The

    Europe Gets Updated HCV Tx Guidelines

    Sunday, April 15, 2018 -- (MedPage Today) -- EASL panel touts "ease of use" of direct-acting antivirals